GuaschA, et al.Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol2006; 17:2228–2235. doi: 10.1681/ASN.2002010084
GuaschA, et al.Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol1999; 10:1014–1019. doi: 10.1681/ASN.V1051014
GuaschA, Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol 1999; 10:1014–1019. doi: 10.1681/ASN.V105101410.1681/ASN.V1051014)| false
CecchiniJ, Outcomes of adult patients with sickle cell disease admitted to the ICU: A case series*. Crit Care Med 2014; 42:1629–1639. doi: 10.1097/CCM.000000000000031610.1097/CCM.0000000000000316)| false
YawnBP, et al.Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA2014; 312:1033–1048. doi: 10.1001/jama.2014.10517 [Erratums in JAMA 2014; 312:1932; JAMA 2015; 313:729].
NationalHeart, Lung, and Blood Institute, National Institutes of Health. Evidence-based management of sickle cell disease. Expert panel report, 2014. 2014. https://www.nhlbi.nih.gov/sites/default/files/publications/56-364NFULL.pdf)| false